Clinical trial
Efficacy and Safety of XP12B in Women With Menorrhagia
NCT00401193 · Ferring Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00401193 |
|---|---|
| Title | Efficacy and Safety of XP12B in Women With Menorrhagia |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study To Evaluate Efficacy and Safety of XP12B for the Treatment of Menorrhagia |
| Lead sponsor | Ferring Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menorrhagia, Heavy Menstrual Bleeding |
| Intervention type | Drug |
| Interventions | Tranexamic acid tablets, Placebo tablets |
| Enrollment | 304 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Nov 20, 2006 |
| Last update posted | May 13, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: